The College of American Pathologists (CAP) Foundation announced today that it has been selected to receive a grant of nearly $95,000 from the Robert Wood Johnson Foundation (RWJF) to evaluate the impact of its See, Test & Treat® cancer screening program on patient engagement and outcomes. Bruce D. Rapkin, Ph.D., professor of epidemiology and population health, Albert Einstein College of Medicine of Yeshiva University, New York, will be the principal investigator for the study.
See, Test & Treat is a CAP Foundation initiative that delivers free, pathologist-led cervical and breast cancer screening, same-day results, and education to vulnerable communities in the U.S. The goal of the See, Test & Treat program is to engage underserved patients in community health care services by offering same-day screening results and immediate access to follow-up care in a culturally appropriate setting.
As physicians, pathologists know the importance of detecting cancer early when it is most treatable. Pathologists who lead See, Test & Treat coordinate collaborative, multidisciplinary care teams who volunteer and help ensure that patients from low-income, minority, and immigrant communities have access to early cancer detection. See, Test & Treat's culturally tailored screenings help eliminate the linguistic, financial, social, and cultural barriers to care while empowering women to take charge of their health.